Disparities in Influenza, Pneumococcal, COVID-19 Vaccine Coverage in High-Risk Adults Aged 19 to 64 Years in Southeastern Minnesota, 2010-2021

被引:3
|
作者
Felzer, Jamie R. [1 ]
Montgomery, Amy J. [2 ]
Lemahieu, Allison M. [3 ]
Rutten, Lila J. Finney [4 ]
Juhn, Young J. [5 ,6 ]
Wi, Chung-Il [5 ,6 ]
Jacobson, Robert M. [4 ,5 ,6 ,7 ]
Kennedy, Cassie C. [1 ,8 ,9 ]
机构
[1] Mayo Clin, Div Pulm & Crit Care, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Med, Rochester, MN USA
[3] Mayo Clin, Div Clin Trials & Biostat, Rochester, MN USA
[4] Mayo Clin, Div Epidemiol, Rochester, MN USA
[5] Mayo Clin, Dept Quantitat Hlth Sci, Div Community Pediat Med, Rochester, MN USA
[6] Mayo Clin, Dept Quantitat Hlth Sci, Div Adolescent Med, Rochester, MN USA
[7] Mayo Clin, Div Pediat Infect Dis, Rochester, MN USA
[8] Mayo Clin, Dept Pediat & Adolescent Med, Div Hlth Care Delivery Res, Rochester, MN 55905 USA
[9] Mayo Clin, Resp Hlth Equ Clin Res Lab, Rochester, MN 55905 USA
基金
美国国家卫生研究院;
关键词
adult; health care disparities; respiratory tract infections; risk factors; sociodemographic factors; vaccines; MEDICAL-RECORDS-LINKAGE; DATA RESOURCE PROFILE; ADVISORY-COMMITTEE; CONJUGATE VACCINE; UNITED-STATES; SOCIOECONOMIC-STATUS; UPDATED RECOMMENDATIONS; POLYSACCHARIDE VACCINE; DISEASE; HEALTH;
D O I
10.1016/j.chest.2024.01.049
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
BACKGROUND: Despite effective vaccines against in fl uenza, pneumococcus, and COVID-19, uptake has been suboptimal. RESEARCH QUESTION: Although disparities in vaccination by race and ethnicity have been observed, what is the role of other sociodemographic factors in US vaccine uptake? STUDY DESIGN AND METHODS: We conducted a population-based study using the Rochester Epidemiology Project (REP), a comprehensive medical records linkage system, to assess effects of sociodemographic factors including race, ethnicity, individual-level socioeconomic status (SES) via the housing-based socioeconomic status index, education, population density (urban or nonurban), and marital status with uptake of in fl uenza, pneumococcal, and COVID-19 vaccination in high-risk adults. Adults at high risk of invasive pneumococcal disease residing in four counties in southeastern Minnesota who were aged 19 to 64 years were identi fi ed. Vaccination data were obtained from the Minnesota Immunization Information Connection and REP from January 1, 2010, through December 31, 2021. RESULTS: We identi fi ed 45,755 residents. Most were White (82%), non-Hispanic (94%), married (56%), and living in an urban setting (81%), with three-quarters obtaining at least some college education (74%). Although 45.1% were up to date on pneumococcal vaccines, 60.1% had completed the primary COVID-19 series. For in fl uenza and COVID-19, higher SES, living in an urban setting, older age, and higher education positively correlated with vaccination. Magnitude of differences in race, education, and SES widened with booster vaccines. INTERPRETATION: This high-risk population is undervaccinated against preventable respiratory diseases, especially in fl uenza and pneumococcus. Although national data reported improvement of disparities in COVID-19 vaccination uptake observed early in the pandemic, our data demonstrated gaps related to race, education level, SES, and age that widened with booster vaccines. Communities with high social vulnerabilities often show increased risk of severe disease outcomes, yet demonstrate lower uptake of preventive services. This highlights the need to understand better vaccine compliance and access in rural, lower SES, lesseducated, Black, Hispanic, and younger populations, each of which were associated independently with decreased vaccination. CHEST 2024; 166(1):49-60
引用
收藏
页码:49 / 60
页数:12
相关论文
共 50 条
  • [31] Predictors of Seasonal Influenza Vaccination Willingness among High-Risk Populations Three Years after the Onset of the COVID-19 Pandemic
    Katsiroumpa, Aglaia
    Sourtzi, Panayota
    Kaitelidou, Daphne
    Siskou, Olga
    Konstantakopoulou, Olympia
    Galanis, Petros
    VACCINES, 2023, 11 (02)
  • [32] Media Coverage of COVID-19 Vaccine Risks in Australia During 2021: Risk Communication During a Rapidly Evolving Situation
    Hooimeyer, Ashleigh
    McEwin, Eliza
    Mohammad, Annim
    Wang, Zhicheng
    Chiu, Kellia
    McDonald, Sally
    Mintzes, Barbara
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 59 - 60
  • [33] Near real-time surveillance of safety outcomes in US COVID-19 vaccine recipients aged 12 to 64 years
    Lloyd, Patricia C.
    Hu, Mao
    Wong, Hui-Lee
    Shoaibi, Azadeh
    Zhou, Cindy Ke
    Lo, An-Chi
    Amend, Kandace
    Beachler, Daniel C.
    McMahill-Walraven, Cheryl N.
    Smith, Elizabeth R.
    Seeger, John
    Secora, Alex
    Djibo, Djeneba Audrey
    Obidi, Joyce
    Feng, Yuhui
    Song, Jennifer
    Reich, Christian
    Harris, Charalynn
    Akhtar, Sandia
    Clifford, Robin
    Selvam, Nandini
    Pigoga, Jennifer L.
    Jiao, Yixin
    Chillarige, Yoganand
    MaCurdy, Thomas
    Forshee, Richard
    Anderson, Steven A.
    VACCINE, 2022, 40 (45) : 6481 - 6488
  • [34] The CDC's Initiative to Address COVID-19 Health Disparities Among High-Risk and Underserved Populations
    Dauphin, Leslie A.
    Liburd, Leandris
    AMERICAN JOURNAL OF PUBLIC HEALTH, 2024, 114 : S540 - S542
  • [35] THE IMPACT OF COVID-19 AND HEALTH DISPARITIES IN HIGH FALL RISK OLDER ADULTS: EXPLORATORY CHART REVIEW
    McFarland, Naomi M.
    De Lima, Bryanna
    Luzod, Hannah
    Kiyoshi-Teo, Hiroko
    ANNALS OF BEHAVIORAL MEDICINE, 2022, 56 (SUPP 1) : S575 - S575
  • [36] Booster and Additional Primary Dose COVID-19 Vaccinations Among Adults Aged ≥65 Years - United States, August 13, 2021-November 19, 2021
    Fast, Hannah E.
    Zell, Elizabeth
    Murthy, Bhavini Patel
    Murthy, Neil
    Meng, Lu
    Scharf, Lynn Gibbs
    Black, Carla L.
    Shaw, Lauren
    Chorba, Terence
    Harris, LaTreace Q.
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2021, 70 (50): : 1735 - 1739
  • [37] Pneumococcal vaccination coverage among adults aged 19 to 64 years with immuno-compromising conditions, cerebrospinal fluid (CSF) leaks, or cochlear implants in the US
    Deb, Arijita
    Mohanty, Salini
    Ou, Wanmei
    Rajagopalan, Srinivasan
    Johnson, Kelly D.
    EXPERT REVIEW OF VACCINES, 2021, 20 (03) : 331 - 345
  • [38] Stroke Risk Following Receipt of COVID-19 Bivalent Vaccines Among US Adults Aged ≥ 65 Years
    Lu, Yun
    Matuska, Kathryn
    Nadimpalli, Gita
    Ma, Yuxin
    Duma, Nathan N.
    Zhang, Henry
    Chiang, Yiyun
    Lyu, Hai
    Chillarige, Yoganand
    Kelman, Jeffrey A.
    Forshee, Richard A.
    Anderson, Steven A.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 35 - 36
  • [39] Translation suppression underlies the restrained COVID-19 mRNA vaccine response in the high-risk immunocompromised group
    Kim, Kangsan
    Narasimhan, Madhusudhanan
    Mahimainathan, Lenin
    Zhang, Ray
    Araj, Ellen
    Kim, Elizabeth
    Tharpe, William
    Greenberg, Benjamin M.
    Greenberg, David E.
    Li, Quan-Zhen
    Cheng, Chi-An
    Sarode, Ravi
    Malladi, Srinivas
    Muthukumar, Alagarraju
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [40] COVID-19 vaccine effectiveness in preventing deaths among high-risk groups in Tamil Nadu, India
    Jaiswal, Anoop
    Subbaraj, V
    Vivian Thangaraj, Jeromie
    Murhekar, Manoj
    Muliyil, Jayaprakash
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2021, 153 (05) : 689 - 691